A Case of Hepatic Carcinoid Tumor Regression with Octreotide.
- Author:
Hee Jin CHOI
1
;
Sang Kyun WOO
;
Kyung Hee SUH
;
Seung Min BAEK
;
Hyo Jong BAEK
;
Sang Moon LEE
;
Won Ho KIM
;
Sung Ho KIM
;
Ik Su KIM
;
Kyung Rak SHON
Author Information
1. Department of Internal Medicine, Taegu Fatima Hospital. rapport@dreamx.net
- Publication Type:Case Report
- Keywords:
Neoplasm/Liver/Metastatic/Carcinoid tumor;
Octreotide
- MeSH:
Carcinoid Tumor*;
Humans;
Liver;
Neoplasm Metastasis;
Neuroendocrine Tumors;
Octreotide*;
Somatostatin
- From:The Korean Journal of Hepatology
2001;7(1):100-103
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Somatostatin analogue octreotide is commonly used for the treatment of carcinoid syndrome. Octreotide also has an antiproliferative effect in neuroendocrine tumors and has demonstrated tumor reduction in patients having advanced carcinoid tumor. This is a case report of a patient who had metastatic liver carcinoid tumor and showed marked regression of liver metastasis after octreotide therapy.
